Serum macrophage migration inhibitory factor in the prediction of preterm delivery.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 18241824.
- Also identified by DOI 10.1016/j.ajog.2007.11.066 and PMC identifier 2532504.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Macrophage migration inhibitory factor is a soluble mediator that helps govern the interaction between cytokines and stress hormones (eg, cortisol). We determined whether maternal macrophage migration inhibitory factor levels predicted subsequent preterm delivery. A nested case-control study measuring serum macrophage migration inhibitory factor concentration at 9-23 weeks' gestation in women who ultimately delivered preterm (n = 60) compared with control women who delivered at term (n = 122). We also examined the connection of macrophage migration inhibitory factor with self-reported psychosocial variables. Macrophage migration inhibitory factor was elevated in the preterm delivery cases (P = .0004), and log macrophage migration inhibitory factor concentration showed a graded response relationship with likelihood of preterm delivery. High-macrophage migration inhibitory factor was also associated with maternal risk-taking behavior, which itself was a risk factor for preterm delivery. Macrophage migration inhibitory factor remained associated independently with preterm delivery after adjusting regression models for several other preterm delivery risk factors (odds ratio, 3.11, 95% confidence interval, 1.54-6.30). High-serum macrophage migration inhibitory concentration in early to midpregnancy is linked with subsequent preterm delivery.
Medical subject headings
- Macrophage Migration-Inhibitory Factors
- Obstetric Labor, Premature
- Pregnancy Complications